๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Fludarabine + ARA-C + G-CSF (FLAG) treatment of newly-diagnosed AML and MDS

โœ Scribed by Estey, E; Plunkett, W; Gandhi, V; Keating, M


Book ID
122525609
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
140 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Fludarabine, cytarabine, and G-CSF (FLAG
โœ Montillo, Marco; Mirto, Salvatore; Petti, Maria Concetta; Latagliata, Roberto; M ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 45 KB ๐Ÿ‘ 2 views

Thirty-eight patients with primary resistant or relapsing acute myeloid leukemia (AML) were treated with fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG). Median age was 41 (range 11-70). Sixteen patients had AML that was primary resistant to induction treatment, while 22 wer